Pain intensity and bioavailability of intramuscular asparaginase and a local anesthetic: A double-blinded study

Pediatric Blood and Cancer

Volumn 44, Issue 3, 2005, Pages 255-258

  Albertsen, Birgitte Klug ^a,b   Hasle, Henrik ^b   Clausen, Niels ^b   Schrøder, Henrik ^b   Jakobsen, Preben ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Asparaginase; Intramuscular administration; Lidocaine; Pharmacokinetics; VAS score

Indexed keywords

ASPARAGINASE; LIDOCAINE; WATER;

ADOLESCENT; ANESTHESIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG DISTRIBUTION; HUMAN; INJECTION; INSTRUMENT STERILIZATION; INTERMETHOD COMPARISON; LYMPHATIC LEUKEMIA; PAIN ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

ADOLESCENT; ANESTHETICS, LOCAL; ANTINEOPLASTIC AGENTS; ASPARAGINASE; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; LEUKEMIA, LYMPHOCYTIC; LIDOCAINE; PAIN; PAIN MEASUREMENT;

EID: 13444257349     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20214     Document Type: Article

References (7)

1. Albertsen BK, Jakobsen P, Schrøder H, et al. Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration. Cancer Chemother Pharmacol 2001;48:77-82.
2. Werber G. Drug Monitoring von Asparaginase im Rahmen des Pädiatrischen Terapieprotokolls der ALL/NHL-BFM 90 Studie, PhD Thesis. Inaugural-Dissertation zur Erlangung des Doktorgrades der Naturwissenschaften im Tachbereich Chemie der Mathematisch-Naturwissenschaftlichen Fakultät der Westfälischen Wilhelms-Universität Münster, Deutschland, 1995; 1-138.
3. Myles PS, Troedel S, Boquest M, et al. The Pain Visual Analog Scale: Is it linear or nonlinear? Anesth Analg 1999;89:1517-1520.
4. Albertsen BK, Schrøder H, Ingerslev J, et al. Comparison of intramuscular therapy with Erwinia asparaginase and Asparaginase Medac: Pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system. Br J Haematol 2001;115:983-990.
5. Boos J, Werber G, Ahlke E, et al. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer 1996;32A:1544-1550.
6. Ahlke E, Nowak-Göttl U, Schulze-Westhoff P, et al. Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukemia. Br J Haematol 1997;96:675-681.
7. Riccardi R, Holcenberg JS, Glaubiger DL, et al. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res 1981;41:4554-4558.